The science behind our Projects
In the realm of mental health research, we are developing the next generation antidepressants using our Prodrug Technology. Depressive diseases, affecting millions globally, has spurred our quest for innovative solutions.
Depression, a complex mental health condition, has posed significant challenges for existing antidepressants. The current pharmacological landscape, primarily centered around targeting neurotransmitters like serotonin, has limitations that necessitate a paradigm shift in treatment approaches.
Understanding the Prodrug Technology
With our prodrug design, we aim to overcome the limitations of existing depression treatments. The driving force behind our commitment is to find more effective solutions and to push the boundaries of the psychiatric science.